Le document Q&A intitulé "Questions and answers for marketing authorisation holders/applicants on the CHMP Opinion for the Article 5(3) of Regulation (EC) No 726/2004 referral on nitrosamine impurities in human medicinal produ
FAQ Impuretés nitrosamines – Acceptable Intake limits
14/04/2023